SAN

82.48

+0.21%↑

SHL.DE

39.95

-2.7%↓

ACB

3.43

-2.83%↓

SAN

82.48

+0.21%↑

SHL.DE

39.95

-2.7%↓

ACB

3.43

-2.83%↓

SAN

82.48

+0.21%↑

SHL.DE

39.95

-2.7%↓

ACB

3.43

-2.83%↓

SAN

82.48

+0.21%↑

SHL.DE

39.95

-2.7%↓

ACB

3.43

-2.83%↓

SAN

82.48

+0.21%↑

SHL.DE

39.95

-2.7%↓

ACB

3.43

-2.83%↓

Search

ICADE.

Closed

SectorHealthcare

21.68 -1.45

Overview

Share price change

24h

Current

Min

21.66

Max

22.04

Key metrics

By Trading Economics

Income

-92M

Sales

-126M

624M

Dividend yield

20.78

Profit margin

-14.707

Employees

969

EBITDA

-95M

138M

Recommendations

By TipRanks

Recommendations

Strong Sell

12 Months Forecast

-14.08% downside

Dividends

By Dow Jones

Dividend yield

Sector Avg

20.78%

2.28%

Next Earnings

17 Feb 2026

Market Stats

By TradingEconomics

Market Cap

-57M

1.6B

Previous open

23.13

Previous close

21.68

News Sentiment

By Acuity

29%

71%

72 / 352 Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

ICADE. Chart

Past performance is not a reliable indicator of future results.

Related News

10 Feb 2026, 23:26 UTC

Major Market Movers

Moderna Stock Slips After FDA Refuses Flu Vaccine Review

10 Feb 2026, 22:31 UTC

Earnings

Correction to America Movil 4Q Profit Article

10 Feb 2026, 22:22 UTC

Earnings

America Movil 4Q Profit Jumps on Lower Financial Costs

10 Feb 2026, 23:51 UTC

Market Talk
Earnings

Commonwealth Bank's Margin Management Gives It a Platform -- Market Talk

10 Feb 2026, 23:42 UTC

Market Talk

Gold Rises Amid Fed Rate-Cut Prospects -- Market Talk

10 Feb 2026, 23:40 UTC

Market Talk
Earnings

Commonwealth Bank Bear Says 1H Result Looks Strong -- Market Talk

10 Feb 2026, 23:21 UTC

Market Talk

Ford Says EV Shift Was Driven by Demand Changes -- Market Talk

10 Feb 2026, 23:21 UTC

Market Talk

Global Equities Roundup: Market Talk

10 Feb 2026, 22:17 UTC

Market Talk

Australia's One Nation Now Commands Working Class Vote -- Market Talk

10 Feb 2026, 22:15 UTC

Earnings

Humana Earnings Will Shed More Light on Medicare Prospects -- Barrons.com

10 Feb 2026, 22:10 UTC

Earnings

Intact Financial 4Q Book Value Per Share Was C$107.35 >IFC.T

10 Feb 2026, 22:10 UTC

Earnings

Intact Financial Raises Qtr Dividend to C$1.47 >IFC.T

10 Feb 2026, 22:09 UTC

Earnings

Intact Financial 4Q Combined Ratio Was 85.9% >IFC.T

10 Feb 2026, 22:09 UTC

Earnings

Intact Financial 4Q Adj EPS C$5.50 >IFC.T

10 Feb 2026, 22:01 UTC

Earnings

Intact Financial 4Q EPS C$5.24 >IFC.T

10 Feb 2026, 21:54 UTC

Earnings

James Hardie Industries Sees FY26 Total Adjusted EBITDA $1.232B to $1.263B >JHX

10 Feb 2026, 21:53 UTC

Earnings

Robinhood Stock Tumbles as Crypto-Related Revenue Falls Short of Expectations -- Barrons.com

10 Feb 2026, 21:51 UTC

Earnings

James Hardie Industries Sees FY26 Free Cash Flow at Least $200M

10 Feb 2026, 21:51 UTC

Earnings

Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. -- Barrons.com

10 Feb 2026, 21:51 UTC

Earnings

James Hardie Industries: Focused on the Achievement of $125 M Target >JHX

10 Feb 2026, 21:51 UTC

Earnings

James Hardie Industries: Integration and Cost Synergies Ahead of Schedule >JHX

10 Feb 2026, 21:51 UTC

Earnings
Acquisitions, Mergers, Takeovers

Evolution Net Debt A$362 Million at Dec. 31 Vs A$1.29 Billion Year Earlier

10 Feb 2026, 21:50 UTC

Earnings
Acquisitions, Mergers, Takeovers

Evolution: Gearing 6% at Dec. 31, From 23% a Year Earlier

10 Feb 2026, 21:50 UTC

Earnings

James Hardie Industries 3Q EPS 12c >JHX

10 Feb 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

10 Feb 2026, 21:50 UTC

Earnings

James Hardie Industries 3Q Adj EPS 24c >JHX

10 Feb 2026, 21:49 UTC

Earnings

James Hardie Industries 3Q Sales $1.24B >JHX

10 Feb 2026, 21:49 UTC

Earnings
Acquisitions, Mergers, Takeovers

Evolution 1H Operating Mine Cash Flow a Record A$1.73 Billion

10 Feb 2026, 21:48 UTC

Earnings
Acquisitions, Mergers, Takeovers

Evolution 1H Ebitda A$1.56 Billion, Up 59% On-Year

10 Feb 2026, 21:47 UTC

Earnings
Acquisitions, Mergers, Takeovers

Evolution 1H Revenue A$2.79 Billion, Up 37% On-Year

Peer Comparison

Price change

ICADE. Forecast

Price Target

By TipRanks

-14.08% downside

12 Months Forecast

Average 18.85 EUR  -14.08%

High 21 EUR

Low 17.4 EUR

Based on 5 Wall Street analysts offering 12 month price targets forICADE. - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Sell

5 ratings

0

Buy

1

Hold

4

Sell

Technical Score

By Trading Central

21.04 / 21.4Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Bullish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

72 / 352 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About ICADE.

Icade is a full-service real estate company with expertise in both commercial property investment (portfolio worth "6.8bn on a full consolidation basis as of 12/31/2023) and property development (2023 economic revenue of "1.3bn) that operates throughout France. Icade has forged longterm partnerships to respond to emerging trends in the industry. It has made climate issues and the preservation of biodiversity central to its business model to reinvent real estate and contribute to more sustainable cities. It is listed as a "SIIC" on Euronext Paris and its leading shareholder is the Caisse des Dépôts group.
help-icon Live chat